 Single reports on rhabdomyolysis in patients on combined therapy with niacin and HMG-CoA reductase inhibitors statins have been reported. Careful monitoring for any signs and symptoms of myopathy such as muscle pain, tenderness, or weakness is therefore required in the case of combination therapy. 